In more details, the NAFLD diagnostic panel [48] recommended five markers (diabetes, gender, BMI, triglycerides and cytokeratin-18 (CK18) fragments) and performed better than the NASH diagnostic [49] that included three biomarkers (CK18, adiponectin and resistin) for NASH prediction. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.